Zhongsheng Pharma's RAY1225 Shows Positive Results in Phase II Trials for Weight Loss and Blood Glucose Reduction
CompanyDrug

Zhongsheng Pharma’s RAY1225 Shows Positive Results in Phase II Trials for Weight Loss and Blood Glucose Reduction

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment
CompanyDeals

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment

China's NMPA Releases Draft Guidelines for Development Risk Management Plan
Policy / Regulatory

China’s NMPA Releases Draft Guidelines for Development Risk Management Plan

AstraZeneca's Calquence Gains EU Approval for Mantle Cell Lymphoma
CompanyDrug

AstraZeneca’s Calquence Gains EU Approval for Mantle Cell Lymphoma

Huadong Medicine's HDM2005 Receives NMPA Approval for DLBCL Clinical Trial
CompanyDrug

Huadong Medicine’s HDM2005 Receives NMPA Approval for DLBCL Clinical Trial

Fresenius Medical Care Reports 1% Revenue Growth in Q1 2025
Company

Fresenius Medical Care Reports 1% Revenue Growth in Q1 2025

Innovent Biologics Completes First Dosing in Phase II Study for Efdamrofusp Alfa in DME
CompanyDrug

Innovent Biologics Completes First Dosing in Phase II Study for Efdamrofusp Alfa in DME

EndoCell Secures RMB 200 Million in Financing to Advance Islet Regeneration Technology
CompanyDeals

EndoCell Secures RMB 200 Million in Financing to Advance Islet Regeneration Technology

Beijing Wantai's HIV Urine Self-Test Kit Gains WHO Prequalification
CompanyMedical Device

Beijing Wantai’s HIV Urine Self-Test Kit Gains WHO Prequalification

Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex for Mexico
CompanyDeals

Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex for Mexico

Shuangcheng Pharma's Generic Bivalirudin Approved by Australia's TGA
CompanyDrug

Shuangcheng Pharma’s Generic Bivalirudin Approved by Australia’s TGA

Everest Medicines' Nefecon Receives Full Approval from NMPA for IgAN Treatment
CompanyDrug

Everest Medicines’ Nefecon Receives Full Approval from NMPA for IgAN Treatment